241 related articles for article (PubMed ID: 14672472)
1. Postpartum varicella vaccination: is the vaccine virus excreted in breast milk?
Bohlke K; Galil K; Jackson LA; Schmid DS; Starkovich P; Loparev VN; Seward JF
Obstet Gynecol; 2003 Nov; 102(5 Pt 1):970-7. PubMed ID: 14672472
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of laboratory methods for diagnosis of varicella.
Leung J; Harpaz R; Baughman AL; Heath K; Loparev V; Vázquez M; Watson BM; Schmid DS
Clin Infect Dis; 2010 Jul; 51(1):23-32. PubMed ID: 20504232
[TBL] [Abstract][Full Text] [Related]
3. Varicella immunity in vaccinated healthcare workers.
Behrman A; Lopez AS; Chaves SS; Watson BM; Schmid DS
J Clin Virol; 2013 Jun; 57(2):109-14. PubMed ID: 23434396
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness over time of varicella vaccine.
Vázquez M; LaRussa PS; Gershon AA; Niccolai LM; Muehlenbein CE; Steinberg SP; Shapiro ED
JAMA; 2004 Feb; 291(7):851-5. PubMed ID: 14970064
[TBL] [Abstract][Full Text] [Related]
5. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
[TBL] [Abstract][Full Text] [Related]
6. Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany.
Wiese-Posselt M; Siedler A; Mankertz A; Sauerbrei A; Hengel H; Wichmann O; Poethko-Müller C
BMC Infect Dis; 2017 May; 17(1):356. PubMed ID: 28525973
[TBL] [Abstract][Full Text] [Related]
7. Primary vaccine failure after 1 dose of varicella vaccine in healthy children.
Michalik DE; Steinberg SP; Larussa PS; Edwards KM; Wright PF; Arvin AM; Gans HA; Gershon AA
J Infect Dis; 2008 Apr; 197(7):944-9. PubMed ID: 18419532
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of varicella zoster virus-specific cell-mediated immunity by using an interferon-γ enzyme-linked immunosorbent assay.
Hayashida K; Ozaki T; Nishimura N; Gotoh K; Funahashi K; Nakane K; Gomi Y; Manabe S; Ishikawa T; Yamanishi K
J Immunol Methods; 2015 Nov; 426():50-5. PubMed ID: 26232696
[TBL] [Abstract][Full Text] [Related]
9. Low induction of varicella-zoster virus-specific secretory IgA antibody after vaccination.
Terada K; Niizuma T; Yagi Y; Miyashima H; Kataoka N; Sadahiro T
J Med Virol; 2000 Sep; 62(1):46-51. PubMed ID: 10935988
[TBL] [Abstract][Full Text] [Related]
10. Investigation of varicella-zoster virus DNA by the polymerase chain reaction in healthy children with varicella vaccination.
Ozaki T; Masuda S; Asano Y; Kondo K; Namazue J; Yamanishi K
J Med Virol; 1994 Jan; 42(1):47-51. PubMed ID: 8308520
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of Oka/Merck varicella vaccine in children vaccinated at 12-14 months of age versus 15-23 months of age.
Silber JL; Chan IS; Wang WW; Matthews H; Kuter BJ
Pediatr Infect Dis J; 2007 Jul; 26(7):572-6. PubMed ID: 17596796
[TBL] [Abstract][Full Text] [Related]
12. Case report: detection of varicella-zoster virus DNA in maternal breast milk.
Yoshida M; Yamagami N; Tezuka T; Hondo R
J Med Virol; 1992 Oct; 38(2):108-10. PubMed ID: 1334125
[TBL] [Abstract][Full Text] [Related]
13. Induction of Immune Response and Protective Immunity by a Local Isolated Varicella Virus in Animal Model: A Future Candidates for Vaccine Production.
Esna-Ashari F; Sabahi F; Ravanshad M; Mohammadi A
Iran J Allergy Asthma Immunol; 2018 Dec; 17(6):586-593. PubMed ID: 30644703
[TBL] [Abstract][Full Text] [Related]
14. The effect of vaccination on the epidemiology of varicella zoster virus.
Edmunds WJ; Brisson M
J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726
[TBL] [Abstract][Full Text] [Related]
15. Immunization of children with malignant diseases with the Oka-strain varicella vaccine.
Austgulen R
Postgrad Med J; 1985; 61 Suppl 4():93-5. PubMed ID: 3014485
[TBL] [Abstract][Full Text] [Related]
16. Laboratory diagnosis and characteristics of breakthrough varicella in children.
Weinmann S; Chun C; Mullooly JP; Riedlinger K; Houston H; Loparev VN; Schmid DS; Seward JF
J Infect Dis; 2008 Mar; 197 Suppl 2():S132-8. PubMed ID: 18419386
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin subclass antibodies to varicella-zoster virus.
Asano Y; Hiroishi Y; Itakura N; Hirose S; Kajita Y; Nagai T; Yazaki T; Takahashi M
Pediatrics; 1987 Dec; 80(6):933-6. PubMed ID: 2825110
[TBL] [Abstract][Full Text] [Related]
18. Serologic analysis of the IgG antibody response in children with varicella zoster virus wild-type infection and vaccination.
Jenke AC; Klein S; Baiker A; Wirth S; Sander M; Noelting C; Boecher O; Vizoso-Pinto MG
Pediatr Infect Dis J; 2012 Nov; 31(11):1148-52. PubMed ID: 22863912
[TBL] [Abstract][Full Text] [Related]
19. Changes in the prevalence of the measles, rubella, varicella-zoster, and mumps virus antibody titers in Japanese pregnant women.
Hanaoka M; Hisano M; Watanabe N; Sugawara K; Kambe Y; Kanda E; Sago H; Kato T; Yamaguchi K
Vaccine; 2013 May; 31(19):2343-7. PubMed ID: 23523405
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of Varicella-Zoster virus IgG antibodies in Swiss children during the first 16 months of age.
Heininger U; Desgrandchamps D; Schaad UB
Vaccine; 2006 Apr; 24(16):3258-60. PubMed ID: 16459000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
